Aker BioMarine ASA (1PG) Stock Statistics & Valuation Metrics

Aker BioMarine ASA has a market cap or net worth of €786.83M. The enterprise value is €6.92B.

Aker BioMarine ASA has 87,703,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aker BioMarine ASA’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is 6.38%.

The current PE Ratio of Aker BioMarine ASA is ―. Aker BioMarine ASA’s PEG ratio is ―.

In the last 12 months, Aker BioMarine ASA had revenue of 224.51M and earned -23.47M in profits. Earnings per share was -0.27.

In the last 12 months, operating cash flow was 47.91M and capital expenditures -22.84M, giving a free cash flow of 25.07M billion.

Aker BioMarine ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Aker BioMarine ASA upcoming earnings date is Apr 30, 2026, TBA (Confirmed).

Aker BioMarine ASA as a current ratio of 2.47, with Debt / Equity ratio of 126.62%

In the past 12 months, Aker BioMarine ASA has paid 0.00 in taxes.

Aker BioMarine ASA EV to EBITDA ratio is 25.82, with an EV/FCF ratio of -584.82.

Aker BioMarine ASA has €16.90M in cash and marketable securities with €147.50M in debt, giving a net cash position of -€165.29M billion.

Gross margin is 40.46%, with operating margin of 9.40%, and net profit margin of -10.45%.

The average price target for Aker BioMarine ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―